Furthermore, AQP4-deficient mice showed increased Aβ and tau pathology and neurodegeneration in mice models of AD (Iliff et al, 2012, 2014; Xu et al, 2015; Abe et al, 2020; Harrison et al, 2020; Ishida et al, 2022). Here, MAPT is linked to Alzheimer disease.